Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2021-07-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety of a single dose of Lu AF82422, how
well it is tolerated, how the drug effects the body and what the body does to the drug in
healthy non-Japanese and Japanese subjects and in patients with Parkinson's disease